Skip to content
Evofem Biosciences, Inc.
About Us
Mission
Management
Board of Directors
Saundra Pelletier
GILLIAN GREER, CBE, Ph.D.
KIM P. KAMDAR, Ph.D.
Tony O’Brien
Lisa Rarick, MD, FACOG
Colin Rutherford
Our Product
phexxi
®
Pipeline
In Development
Posters & Publications
Investors
Investor Overview
Events & Presentations
Press Releases
Stock Information
Financial Information
SEC Filings
Analyst Coverage
Corporate Governance
Committee Composition
Board of Directors
Charters + Code of Ethics
Investor Resources
Investor Contact
Investor FAQs
Contact
Investor Contact
Media Contact
General Contact
Careers
Perfect-Use Pregnancy Rates with Vaginal pH Regulator: Efficacy Results from AMPOWER
Post navigation
Previous:
Efficacy and Safety of Vaginal pH Regulator for Prevention of Chlamydia and Gonorrhea
Next:
Characterization of Women According to Pregnancy Status Following Treatment with VPR During the AMPOWER Study
Back
to
Top
